Amyotrophic Lateral Sclerosis is usually discussed as a medical tragedy affecting individual patients and families. That is true, but it is no longer the whole picture.
Modern technology has quietly changed the meaning of severe paralysis.
Ventilators can replace respiratory muscles for decades. Feeding tubes can replace swallowing. Eyegaze systems can restore communication and computer access even after nearly all voluntary movement is lost. A fully paralyzed person may remain intellectually active long after the body itself has failed mechanically. This book, for example, was written in a couple of weeks, entirely unassisted, using only eyegaze technology.
For most of modern medical history, severe paralysis often led relatively quickly to silence, institutionalization, and death. Care systems evolved around that expectation. The goal was usually to manage decline rather than to support long-term survival. There was little practical reason to optimize communication systems, long-term comfort, energy conservation, or highly refined home care for patients assumed to have limited time remaining.
But technology moved faster than the surrounding culture. That creates tension that healthcare systems have not fully adapted to.
Long-term survival with advanced paralysis is expensive, labor-intensive, and structurally difficult. It requires caregivers, equipment, housing adaptation, respiratory support, communication systems, and continuous practical maintenance. At the same time, the number of patients wanting aggressive life support is gradually increasing because communication technology has made meaningful long-term survival more realistic than previous generations imagined.
The deeper issue is that society still tends to evaluate paralysis from the outside. Healthy people imagine loss of movement while unconsciously assuming that movement itself is the foundation of human existence. But humans adapt. Priorities change. Energy conservation becomes instinctive. Communication replaces physical activity as the primary interface with the world. Stability becomes more valuable than performance.
A ventilated patient with good communication tools, stable routines, effective secretion management, minimal unnecessary strain, proper caregiver training, and freedom to participate intellectually may experience life very differently from what healthy observers imagine. More and more patients will choose long-term survival. And unlike previous generations, they now have the ability to describe publicly what happens when support systems fail, adaptation is denied, or survival itself is discouraged or even denied.
Preventing paralysis in the first place is therefore the only sustainable way. We already have most of the pieces. It is time to get to work. Hopefully, this book will provide some inspiration.
***
Incurable diseases are not only a human tragedy. They are also a growing structural burden on society.
When a person develops a chronic, progressive disease, the costs extend beyond healthcare expenses. It spreads everywhere:
- lost productivity
- disability support
- long-term care
- reduced tax revenue
- exhausted families and caregivers
- shrinking workforce participation
And in aging societies, every net payer counts.
We still often talk about medical research as an expense. But curing or halting major chronic diseases is closer to infrastructure investment. Every person who remains healthy, independent, and able to work longer strengthens the entire system.
The problem is that many of these diseases are not simple. They are system-level failures involving metabolism, protein regulation, inflammation, signaling pathways, energy balance, the immune response, and feedback loops that interact over the course of decades.
That complexity has exceeded what humans can reliably model mentally.
But for the first time, we now have tools that can operate at system scale.
AI is not just faster statistics. Properly applied, it can analyze enormous multidimensional datasets, identify hidden interactions, recognize non-obvious patterns, and generate hypotheses that humans would never reach on their own.
That matters especially for diseases where reductionist approaches have stalled progress for years.
The potential value is enormous. Not only morally, but economically.
A cure for a major chronic disease does not merely save treatment costs. It returns people to life, work, creativity, and society itself.
In a world struggling with demographics, labor shortages, and rising healthcare costs, disease cures should increasingly be viewed not as consumption, but as investment.
***
A disease cannot simultaneously be described as too rare to justify serious research funding, yet so common and expensive that society cannot afford to keep willing patients alive.
Those two arguments directly contradict each other.
The confusion comes from mixing up prevalence and incidence.
ALS has low prevalence because it kills quickly. People do not live with it for decades the way they do with diabetes, spinal injuries, or many cancers. Short survival keeps the number of living patients artificially low at any given moment.
But incidence tells a different story.
Roughly 1 in 500 people will develop ALS during their lifetime. That is not some vanishingly rare lightning strike. In Finland alone, around 10 000 people currently alive today will eventually die of ALS if nothing changes.
Imagine if all of them suddenly knew it in advance.
There would be national panic. Emergency funding programs. Demands for accelerated drug development. Endless headlines asking why so little had been done.
But disease does not announce itself that way. It arrives one diagnosis at a time.
And so the reaction remains fragmented. Each newly diagnosed person feels isolated and asks, “why me?” even though hundreds of others are entering the same reality every year at that exact moment.
That isolation is partly an illusion created by statistics.
ALS does not look common because it does not leave many survivors behind to be counted.
***
For a long time, doctors effectively held a monopoly over the public narrative of paralysis. Patients with severe disability had little ability to communicate independently, little visibility, and almost no way to describe their own lives to society. What the medical system said became reality.
And decades ago, much of that narrative was true.
A quadriplegic patient without reliable communication was trapped behind other people’s interpretations. Dependence was nearly total. Life became socially invisible. Physicians witnessed isolation, institutionalization, and progressive decline—and concluded that such a life was inherently unbearable.
But technology changed both sides of the equation.
Eyegaze communication gave fully paralyzed people direct access to computers. For the first time, patients could participate continuously in society rather than being spoken for by others.
That changed something fundamental.
The system could no longer describe paralysis only from the outside. Patients began documenting their own lives publicly. They started explaining in real time what existence with paralysis actually feels like from the inside.
The old narrative has not disappeared, but it is increasingly difficult to maintain.
Many physicians still operate psychologically inside a late 20th-century framework where invasive ventilation in ALS is viewed mainly as prolongation of dying rather than continuation of life. But the internet age makes information impossible to contain. Thousands of ventilator users now openly demonstrate that meaningful life after paralysis is entirely possible.
That creates tension that the healthcare system has not fully adapted to.
Every involuntary death now raises scrutiny. Every refusal of ventilation, communication access, cough assist support, or long-term care is discussed publicly by patients themselves. Explanations that once remained inside hospital walls are now compared internationally in real time.
At the same time, the number of ALS patients wanting long-term survival is growing. Society is slowly discovering that once communication and respiratory support exist, many patients do not actually want to die.
That creates an uncomfortable reality: providing long-term invasive support to large numbers of severely paralyzed people is expensive, labor-intensive, and structurally difficult. The temptation is to frame refusals as “medical futility” or “poor quality of life” even when the patient disagrees.
But that position becomes harder to sustain each year as patients continue speaking publicly for themselves.
In the end, there is only one durable solution.
We simply need to find a cure.
***
Paralysis does not make a person useless. It only changes the interface between the mind and the world.
Society often makes the mistake of measuring human value solely by physical productivity. That view belongs to an industrial era in which contribution was mainly associated with manual labor and mobility. But we now live in an information society. A person who can think clearly and communicate effectively can still contribute enormously, even from a bed and through a screen.
In many ways, severe paralysis exposes how primitive our assumptions about disability still are. People see an immobile body and unconsciously assume the person is absent-minded. Yet history is full of individuals whose physical limitations had little connection to the value of their intellectual work. The bottleneck is often not the disease itself, but whether society provides proper assistive technology and allows the person to keep participating.
Eyegaze communication is not merely a convenience device. It is a pathway of replacement between the brain and the outside world. Once that pathway exists, meaningful participation becomes possible again.
The real tragedy is not paralysis. The real tragedy is when society quietly gives up on people who are still fully capable of contributing.
***
The system has not fully understood what eyegaze technology means, as it still operates on assumptions from an earlier era of paralysis care. The old model depended heavily on silence, dependency, and gradual withdrawal from society. A person who could no longer speak or move eventually lost the practical ability to participate, question decisions, or resist institutional inertia. Communication itself became exhausting.
Eyegaze changes that.
A fully paralyzed person can now communicate independently and continuously. Not through an assistant interpreting fragments, but directly. That fundamentally changes the relationship between patients with paralysis and the healthcare system.
We no longer quietly agree to die.
Patients can compare treatment practices internationally, discuss experiences with others online, challenge outdated assumptions, and publicly document failures. We can coordinate our own care, follow research in real time, and demand explanations rather than passively accept whatever happens around us. The old expectation was that severe paralysis would naturally produce silence and compliance. Technology broke that expectation.
That shift is uncomfortable for institutions built around paternalistic care models. A ventilated quadriplegic lying motionless in bed still looks passive from the outside. But behind the eyegaze screen may be someone reading clinical papers, writing technical critiques, organizing advocacy, or exposing systemic failures in public.
The implications are enormous because the limiting factor is no longer physical movement. It is access.
Once communication bandwidth is restored, the patient ceases to be merely a target of care and becomes an active participant again. The healthcare system is still adapting to the fact that paralysis patients are no longer isolated individuals disappearing quietly behind closed doors.
We are online now.